Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

21
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
21
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic delay and onset-anchored clinical milestones in progressive supranuclear palsy: a japanese single-center retrospective cohort study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Association between the peptide spectrum match values of LGI1, ADAM22, ADAM23 and DLG4 in the immunoprecipitation products of five autoimmune encephalitis cases with LGI1 antibody: A case series.

Internal medicine (Tokyo, Japan)·2026
Same author

Early respiratory decline around diagnosis and short-term post-landmark outcomes in amyotrophic lateral sclerosis: a 6-month landmark cohort study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Nationwide screening identifies an expanded clinical spectrum of anti-KLHL11 antibody-associated neurologic disease in Japan.

Journal of neurology·2026
Same author

Two-dimensional metal-organic frameworks offer all-in-one cocatalysts for photocatalytic overall water splitting.

Nature chemistry·2026
Same author

Prevalence and profiles of clinically diagnosed autoimmune cerebellar ataxia in a Japanese nationwide survey.

Journal of neurology·2026
Same journal

From Proof-of-Concept to Decision-Grade Cerebellar Neurostimulation: A Precision-and-Governance Pipeline for Globally Scalable Balance Interventions.

Cerebellum (London, England)·2026
Same journal

Adult-Onset SCAR4 with a 30-Year Slowly Progressive Course: First Combined Assessment with FDG-PET and Brain Perfusion SPECT.

Cerebellum (London, England)·2026
Same journal

Clinical and Radiological Variability in Episodic Ataxia Type 2: A Case Report and Review of the Literature.

Cerebellum (London, England)·2026
Same journal

Trends and Disparities in Mortality from Hereditary Ataxia in United States, 2000-2020: A Retrospective Analysis with Projections to 2050.

Cerebellum (London, England)·2026
Same journal

Phenotype and Genetics of Spinocerebellar Ataxia Type 27B: Novel Movement-disorder Features, Cognitive Impairment, and Repeat Expansion Findings.

Cerebellum (London, England)·2026
Same journal

Clinical and Genetic Characteristics of SCA27B: A Global Systematic Review and Meta-Analysis.

Cerebellum (London, England)·2026
See all related articles

Related Experiment Video

Updated: Sep 8, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K

Trends in Invasive Interventions and Risk Factors for Early Critical Events in Multiple System Atrophy.

Monami Tarisawa1,2,3, Masaaki Matsushima1, Akihiko Kudo1

  • 1Department of Neurology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Cerebellum (London, England)
|September 6, 2025
PubMed
Summary
This summary is machine-generated.

Invasive treatments are common in Multiple System Atrophy (MSA). Autonomic dysfunction, sleep apnea, and vocal cord issues predict early death, even in patients with preserved daily living activities.

Keywords:
Care levelHoRC-MSAMSAMultiple system atrophyRisk factorsmRS

More Related Videos

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.9K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K

Related Experiment Videos

Last Updated: Sep 8, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

19.9K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K

Area of Science:

  • Neuroscience
  • Clinical Neurology
  • Rare Diseases

Background:

  • Multiple System Atrophy (MSA) is a progressive neurodegenerative disorder.
  • Autonomic failure, cerebellar ataxia, and parkinsonism characterize MSA.
  • Invasive interventions and sudden death are common in MSA patients.

Purpose of the Study:

  • To identify patterns of invasive treatment in MSA patients.
  • To determine risk factors for tracheostomy or sudden death within five years of onset.
  • To analyze the impact of interventions on survival and identify early critical event predictors.

Main Methods:

  • Retrospective analysis of 214 MSA patients from the Hokkaido Rare Disease Consortium for MSA (HoRC-MSA).
  • Grouped patients by clinical course and interventions, analyzing various invasive procedures.
  • Multivariable analyses identified risk factors for early critical events (tracheostomy or sudden death within 5 years).

Main Results:

  • Invasive procedures were used in 63.1% of patients; enteral nutrition and tracheostomy correlated with prolonged survival.
  • Early critical events were associated with older onset age, orthostatic hypotension, stridor, and elevated apnea-hypopnea index.
  • Preserved activities of daily living (ADL) also increased the risk of early critical events.

Conclusions:

  • Autonomic dysfunction, sleep-disordered breathing, and vocal cord impairment are key predictors of early mortality in MSA.
  • Continuous monitoring is crucial for MSA patients, irrespective of their preserved ADL.
  • Further research is needed on the quality of life impact of invasive interventions in MSA.